Clinical Trials

Showing 1–12 of 139 results

Without safe and well-designed clinical trials, drug development would lack necessary direction and evaluation. The industry knows how valuable clinical trials are and so do we. Our reports explore the myriad facets of this dynamic and crucial process to provide pertinent information to organizations that rely on clinical research outcomes.

  • Phase II/III CRO Benchmarking (16th Ed.)
    Select options

    Phase II/III CRO Benchmarking (16th Ed.)

    $4,900.00 – $9,900.00
  • Central Lab Benchmarking and Market Dynamics (3rd Ed.)
    Select options

    Central Lab Benchmarking and Market Dynamics (3rd Ed.)

    $4,900.00 – $9,900.00
  • Select options

    eCOA/ePRO Benchmarking and Market Dynamics (5th Ed.)

    $5,650.00 – $11,300.00
  • Select options

    Clinical Development Outsourcing Models (5th Ed.)

    $5,650.00 – $11,300.00
  • Select options

    EDC Benchmarking and Market Dynamics (5th Ed.)

    $5,650.00 – $11,300.00
  • Select options

    Phase II/III CRO Benchmarking – Small Pharma Market (4th Ed.)

    $4,550.00 – $9,100.00
  • Select options

    2023 CRO Market Size and Growth Projections

    $1,195.00 – $2,390.00
  • Select options

    Phase II/III CRO Benchmarking (15th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Phase I CRO Benchmarking (15th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Decentralized Clinical Trials Market Outlook

    $5,650.00 – $11,300.00
  • Select options

    Bioanalytical Labs Market Dynamics and Service Provider Performance (5th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Phase I Market Outlook: 2022-2026

    $5,650.00 – $11,300.00